Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 12 05 2021
accepted: 08 06 2021
entrez: 12 7 2021
pubmed: 13 7 2021
medline: 3 8 2021
Statut: epublish

Résumé

During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to draw a complete trajectory of infection. The patient has been monitored for the whole length of infection, assessing the temporal viral load decay, the quantification of viral RNA and subgenomic mRNA, antibodies (anti Sars-CoV-2, IgA, IgG, IgM) and cell-mediated (cytokine, B- and T-cell profiles) responses. Overall, this brief report highlights the efficacy of vaccine in preventing COVID19 disease, accelerating the recovery from infection, reducing the transmission risk, although the use of precautionary measures against Sars-CoV-2 spreading still remain critical.

Identifiants

pubmed: 34249017
doi: 10.3389/fimmu.2021.708820
pmc: PMC8270685
doi:

Substances chimiques

COVID-19 Vaccines 0
RNA, Viral 0
BNT162 Vaccine N38TVC63NU

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

708820

Informations de copyright

Copyright © 2021 Strafella, Caputo, Guerrera, Termine, Fabrizio, Cascella, Picozza, Caltagirone, Rossini, Balice, Salvia, Battistini, Borsellino and Giardina.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Euro Surveill. 2021 Jan;26(3):
pubmed: 33478625
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Sci Immunol. 2020 Jun 26;5(48):
pubmed: 32591408
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Expert Opin Biol Ther. 2020 Aug;20(8):831-836
pubmed: 32380868
J Med Virol. 2021 Mar;93(3):1210-1211
pubmed: 32966614
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
Lancet. 2021 Apr 10;397(10282):1351-1362
pubmed: 33798499
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941

Auteurs

Claudia Strafella (C)

Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy.
Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.

Valerio Caputo (V)

Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy.
Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.

Gisella Guerrera (G)

Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy.

Andrea Termine (A)

Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy.

Carlo Fabrizio (C)

Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy.

Raffaella Cascella (R)

Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy.
Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.

Mario Picozza (M)

Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy.

Carlo Caltagirone (C)

Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.

Angelo Rossini (A)

Medical Services, IRCCS Santa Lucia Foundation, Rome, Italy.

Maria Pia Balice (MP)

Clinical Microbiology Laboratory, IRCCS Santa Lucia Foundation, Rome, Italy.

Antonino Salvia (A)

Medical Services, IRCCS Santa Lucia Foundation, Rome, Italy.

Luca Battistini (L)

Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy.

Giovanna Borsellino (G)

Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy.

Emiliano Giardina (E)

Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy.
Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH